We are live on ! Find out more
NVO

Novo Nordisk
NVO

411 hedge funds and large institutions have $5.8B invested in Novo Nordisk in 2013 Q2 according to their latest regulatory filings, with 411 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $89.1M | Put options by funds: $42.3M

84.64% more ownership

Funds ownership: 0% → 84.64% (+85%)

Holders
411
Holders Change
+411
Holders Change %
–
% of All Funds
13.41%
Holding in Top 10
12
Holding in Top 10 Change
+12
Holding in Top 10 Change %
% of All Funds
0.39%
New
411
Increased
–
Reduced
–
Closed
–
Calls
$89.1M
Puts
$42.3M
Net Calls
+$46.8M
Net Calls Change
+$46.8M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1IC
76
1919 Investment Counsel
Maryland
$7.39M +$7.93M +476,650 New
RBCM
77
Raub Brock Capital Management
California
$7.29M +$7.83M +470,670 New
Citigroup
78
Citigroup
New York
$7.21M +$7.74M +465,080 New
Susquehanna International Group
79
Susquehanna International Group
Pennsylvania
$7.13M +$7.66M +460,110 New
GC
80
Gratry & Company
Ohio
$7.11M +$7.63M +458,680 New
CCM
81
Chautauqua Capital Management
Colorado
$6.97M +$7.49M +449,850 New
WAM
82
World Asset Management
Michigan
$6.92M +$7.43M +446,510 New
AP
83
Archon Partners
New Jersey
$6.88M +$7.39M +444,000 New
CL
84
CIM LLC
New York
$6.73M +$7.23M +434,180 New
Natixis Advisors
85
Natixis Advisors
Massachusetts
$6.47M +$6.95M +417,860 New
HTI
86
Hikari Tsushin Inc
Japan
$6.44M +$6.92M +415,800 New
FNYS
87
First New York Securities
New York
$6.43M +$6.91M +415,000 New
ARTA
88
A.R.T. Advisors
New York
$6M +$6.44M +387,000 New
CC
89
Curian Capital
Colorado
$5.65M +$6.07M +364,670 New
JFL
90
Jarislowsky, Fraser Ltd
Quebec, Canada
$5.54M +$5.95M +357,450 New
RCG
91
Ruane, Cunniff & Goldfarb
New York
$5.37M +$5.77M +346,400 New
GXMC
92
Global X Management Company
New York
$5.32M +$5.72M +343,370 New
TAM
93
Trillium Asset Management
Massachusetts
$5.3M +$5.69M +341,930 New
NAM
94
North American Management
Massachusetts
$5.25M +$5.64M +339,070 New
OC
95
Oppenheimer & Co
New York
$5.16M +$5.54M +332,870 New
NCGI
96
Next Century Growth Investors
Minnesota
$5.15M +$5.53M +332,380 New
GIM
97
Goelzer Investment Management
Indiana
$5.08M +$5.45M +327,640 New
Fifth Third Bancorp
98
Fifth Third Bancorp
Ohio
$4.91M +$5.27M +316,790 New
IG
99
ING Group
Netherlands
$4.9M +$5.26M +315,820 New
CA
100
Commerzbank Aktiengesellschaft
Germany
$4.83M +$5.18M +311,350 New
2 3
4
5 6

NVO Hedge Fund Activity: Q2 2013 in Review

411 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2013, worth a combined $5.8B.

Buyers outnumbered sellers: 411 funds opened new NVO positions and 0 closed out — a net gain of 411 holders — while 0 added to existing stakes and 0 trimmed.

  • 411 institutional investors held Novo Nordisk (NVO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.8B of Novo Nordisk stock for Q2 2013.
  • 411 funds opened new Novo Nordisk positions in Q2 2013 and 0 closed out, a net change of +411 holders.

Based on aggregated 13F filings for Q2 2013.